Aveir VR Coverage With Evidence Development Post-Approval Study

Recruiting now

Conditions studied: Cardiac Pacemaker, Arrythmia, Bradycardia

In brief

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Single-Chamber Leadless Pacemaker device (Aveir VR LP).

Key facts

Study ID

NCT05336877

Run by

Abbott Medical Devices

People needed

8744

Starts

2022-06-21

Expected to finish

2028-01-01

Last updated by the study team

2025-07-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Medicare beneficiaries implanted with an Aveir VR leadless pacemaker on or after the study start date (i.e., the date of Aveir VR market approval) will be included in the study.
• OR
• Medicare beneficiaries implanted with a full system (e.g. lead and generator) single-chamber ventricular transvenous pacemaker on or after the study start date

You may not qualify if…

• None

Where it is running

• Abbott — Sylmar, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.